Apr 29, 2020
Amplyx Pharmaceuticals to Participate in Antifungal Panel at Maxim Group's Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector
Feb 18, 2020
m8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil
Nov 05, 2019
Visiongain Report Claims There is Huge Potential Within the $141bn Anti-Infective Agents Market
Aug 09, 2019
Visiongain Report Looks at Opportunities Within the $17bn Antifungal Drugs Market
Jun 03, 2019
"Superbugs" Are No Match for the Advanced Penetration Technology(TM) Topical Platform
May 06, 2019
SCYNEXIS Presents Data at ACOG 2019 Further Supporting a Future NDA Submission of Oral Ibrexafungerp for Vulvovaginal Candidiasis (VVC)
Mar 18, 2019
The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025
Feb 18, 2019
Global Antifungal Drugs Market, 2013-2018 & 2023 - Increasing Popularity of OTC Drugs, Increase in Availability of Innovative Antifungals & Growing Prevalence of Candidiasis and Aspergillosis
Feb 07, 2019
The candidiasis drugs market will register a CAGR of almost 4% by 2023
Jan 30, 2019
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States
Dec 11, 2018
Mayne Pharma receives FDA approval of Tolsura(TM) (SUBA®-itraconazole capsules) for the treatment of certain fungal infections
Nov 13, 2018
SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update
Oct 01, 2018
SCYNEXIS Supports AMR Challenge and Fungal Disease Awareness Week
Aug 14, 2018
Blueberry Therapeutics Limited Closes £10m Funding to Support Development of Nanomedicines Portfolio
Jun 07, 2018
Amplyx Announces Presentations on APX001 at American Society for Microbiology Microbe 2018 and the 20th Symposium on Infections in the Immunocompromised Host
Apr 10, 2018
SCYNEXIS to Present SCY-078 Data at the 28th European Congress of Clinical Microbiology and Infectious Disease (ECCMID)
Mar 20, 2018
SCYNEXIS Presents Data at Superbugs and Superdrugs 2018
Nov 22, 2017
SCYNEXIS to Present at the 29th Annual Piper Jaffray Healthcare Conference
Oct 03, 2017
Pulmatrix Antifungal Drug Candidate Receives a Second "Qualified Infectious Disease Product" (QIDP) Designation from the FDA
Oct 02, 2017
Tabuk Pharmaceuticals Signs License and Supply Agreement With Selectchemie